Detalhe da pesquisa
1.
Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell-depleted hematopoietic cell transplantation in pediatric and young adult patients.
Cytotherapy
; 26(4): 351-359, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349310
2.
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma.
Pediatr Blood Cancer
; 70(1): e29921, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934994
3.
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients.
Cytotherapy
; 24(4): 428-436, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35042670
4.
Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL.
Blood
; 134(26): 2361-2368, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31650176
5.
Incidence of Anicteric Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome and Outcomes with Defibrotide following Hematopoietic Cell Transplantation in Adult and Pediatric Patients.
Biol Blood Marrow Transplant
; 26(7): 1342-1349, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32200121
6.
Pooled analysis of Day 100 survival for defibrotide-treated patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome and ventilator or dialysis dependence following haematopoietic cell transplantation.
Br J Haematol
; 190(4): 583-587, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32157682
7.
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation.
Cytotherapy
; 22(9): 503-510, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622752
8.
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
Blood
; 129(16): 2308-2315, 2017 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28179273
9.
Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.
Biol Blood Marrow Transplant
; 24(5): 1057-1062, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287807
10.
Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome.
Br J Haematol
; 181(6): 816-827, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767845
11.
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Blood
; 127(13): 1656-65, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825712
12.
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Pediatr Blood Cancer
; 65(10): e27269, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873895
13.
Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using "Low-dose" Cyclophosphamide, ATG Plus Fludarabine.
J Pediatr Hematol Oncol
; 40(4): e220-e224, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432302
14.
Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
Biol Blood Marrow Transplant
; 23(3): 475-482, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040534
15.
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Biol Blood Marrow Transplant
; 23(6): 997-1004, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28285079
16.
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.
Biol Blood Marrow Transplant
; 23(11): 1879-1886, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28694182
17.
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.
Biol Blood Marrow Transplant
; 23(12): 2088-2095, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28711727
18.
Ex Vivo CD34+-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response.
Biol Blood Marrow Transplant
; 23(3): 452-458, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017734
19.
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Br J Haematol
; 178(1): 112-118, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28444784
20.
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.
Blood
; 125(1): 199-205, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377785